Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Day One Biopharmaceuticals Inc 2000 Sierra Point Parkway Suite 501 Brisbane CA 94005 USA

www.dayonebio.com P: 650-484-0899

Description:

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 1,453,953
Enterprise Value, $K 1,223,173
Shares Outstanding, K 87,377
Annual Sales, $ 0 K
Annual Net Income, $ -188,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -54,510 K
EBIT, $ -206,070 K
EBITDA, $ -205,690 K
60-Month Beta -1.48
% of Insider Shareholders 8.40%
% of Institutional Shareholders 87.95%
Float, K 80,037
% Float 91.60%
Short Volume Ratio 0.61

Growth:

1-Year Return 10.80%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.64 on 02/26/24
Latest Earnings Date 05/06/24
Earnings Per Share ttm -2.38
EPS Growth vs. Prev Qtr -18.52%
EPS Growth vs. Prev Year -14.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DAWN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.66%
Return-on-Assets % -48.30%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.76
Book Value/Share 3.98
Interest Coverage -1.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar